Our objective in this study was to determine the costeffectiveness of hepatitis A vaccination strategies in healthy adults in the United States. We constructed a decision model simulating costs and health consequences for otherwise healthy adults with respect to hepatitis A prevention. Three strateg
β¦ LIBER β¦
A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis
β Scribed by B.S. Bloom; A.L. Hillman; A.M. Fendrick; J.S. Schwartz
- Book ID
- 118891568
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 136 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0020-7292
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cost-effectiveness analysis of hepatitis
β
J. Barry O'Connor; Thomas F. Imperiale; Mendel E. Singer
π
Article
π
1999
π
John Wiley and Sons
π
English
β 97 KB
π 1 views
Cost-effectiveness analysis of prenatal
β
G. Tormans; P. Van Damme; G. Carrin; R. Clara; W. Eylenbosch
π
Article
π
1993
π
Elsevier Science
π
English
β 916 KB
Cost-effectiveness analysis of vaccinati
β
E. van Doorslaer; G. Tormans; P. van Damme
π
Article
π
1994
π
John Wiley and Sons
π
English
β 605 KB
## Abstract Hepatitis A virus (HAV) infection is a substantial risk for travellers from low endemic countries to high endemic destinations. Costs and effects of alternative options for prevention were compared using formal decision analysis. General indications for the optimal prevention of hepatit
Cost effectiveness of hepatitis A/B vers
β
R. Jake Jacobs; Philip Rosenthal; Allen S. Meyerhoff
π
Article
π
2004
π
Elsevier Science
π
English
β 92 KB
Analysis of cost-effectiveness of differ
β
J. Y. KANG; T. P. LEE; I. YAP; K. C. LUN
π
Article
π
1992
π
John Wiley and Sons
π
English
β 492 KB
Cost-effectiveness of hepatitis A and B
β
Thomas Szucs
π
Article
π
2000
π
Elsevier Science
π
English
β 83 KB